Dr. Miller is a practicing Clinical Geneticist at Boston Children's Hospital, and Associate Molecular Pathologist at Brigham and Women's Hospital. His clinical and research interests are in Neurofibromatosis, neurodevelopmental disorders, and clinical genetic test implementation and utility,'particularly for chromosomal microarray and exome sequencing. He directs the Neurofibromatosis Research Initiative (NFRI) at Boston Children's Hospital. Through the NFRI, he created the international Genomics of MPNST (GeM) Consortium, an effort to characterize the genomic architecture of this rare NF1-related tumor to improve clinical management. He has led or served on several national committees and advisory boards focused on best practices for clinical genetics and genetic testing, including: Chair of ACMG's Professional Practice and Guidelines Committee; Co-Chair of ACMG's Secondary Findings Maintenance Working Group; Member of ACMG's Evidence-Based Medicine Working Group and Topic Selection Committee. Dr. Miller is Associate Professor of Pediatrics at Harvard Medical School where he is also Co-Director of the Advanced Integrated Science Course in Human Genetic